Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Cash from Investing Activities came in at $9.7 million in Q3 2025, up 2069.92% year-on-year from $446652.7 in Q3 2024, and down 34.6% on a QoQ basis from $14.8 million in Q2 2025.

Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Cash from Investing Activities data on file, last reported at $9.7 million in Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million in Q3 2025; TTM through Sep 2025 was $43.6 million, a 1814.16% increase from a year earlier, with the FY2024 full-year figure at $6.9 million, up 114.99% from the prior year.
  • Cash from Investing Activities for Q3 2025 stood at $9.7 million, down from $14.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RBOT reached as high as $14.8 million in Q2 2025 and fell as low as -$43.8 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$865105.3 across 5 years, with a median of -$492000.0 in 2024.
  • Across the five-year window, Cash from Investing Activities sank 2067.56% in 2023 and jumped 3303.47% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$867000.0 in 2021, then slipped by 14.42% to -$992000.0 in 2022, then surged by 608.57% to $5.0 million in 2023, then surged by 186.42% to $14.4 million in 2024, then plunged by 32.93% to $9.7 million in 2025.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $9.7 million in Q3 2025, $14.8 million in Q2 2025, and $4.6 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -20.32 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -185.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -92.80 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -298.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -475.32 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -2.50 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Vicarious Surgical 654,984.55 -9.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 9.69 Mn
Sep 30, 2025 9.69 Mn
Jun 30, 2025 14.82 Mn
Jun 30, 2025 14.82 Mn
Mar 31, 2025 4.61 Mn
Mar 31, 2025 4.61 Mn
Dec 31, 2024 14.45 Mn
Dec 31, 2024 14.45 Mn
Sep 30, 2024 -492,000.00
Sep 30, 2024 -492,000.00
Jun 30, 2024 -6.95 Mn
Jun 30, 2024 -6.95 Mn
Mar 31, 2024 -144,000.00
Mar 31, 2024 -144,000.00
Dec 31, 2023 5.05 Mn
Dec 31, 2023 5.05 Mn
Sep 30, 2023 -644,000.00
Sep 30, 2023 -644,000.00
Jun 30, 2023 -6.36 Mn
Jun 30, 2023 -6.36 Mn